Chemyx: Sustained-Release Therapeutic Carriers - The Microencapsulation of Cells

Cell microencapsulation is a novel and promising strategy in various disease settings. Syringe-based infusion pump apparatuses provide for a controlled release of the bioactive agents.

Chemyx Inc.
Jan 28, 2018
The entrapment of viable and functional cells within a semi-permeable membrane for protected and sustained biotherapeutic delivery is a novel and promising cell-based strategy in various disease settings. Critical to the success of cell microencapsulation is membrane permeability; those molecules essential for maintaining cell viability should be able to enter, and those necessary for the therapeutic effect should be able to exit. Researchers will often consider structure, chemical composition, and degree of cross-linking when determining whether the matrix should function as a mechanical or chemical (or both) barrier to best suit their purpose.
 
To ensure your time and resources are not wasted during and after the fine-tuning of capsule material and pore size, automated systems can provide for a controlled release of the bioactive agents. To that end, each prospective application requires a reliable and customizable solution. Manual microfluidic manipulation requires high-level training at a scale of measure...
 
Microencapsulation: Agents & Applications
 
In culture and in vivo cell-microencapsulation has been accomplished using a person’s own cells (autologous), a donor’s cells (allogeneic), or another species’ cells (xenogeneic) for the immuno-protected and continuous release of the bioactive agents they produce. The semi-permeable membrane required for encapsulation has largely been of the hydrogel sort and polysaccharide-based, using agarose, alginate, chitosan, gelatin, collagen, among others, of which alginate is most-readily available and therefore widely used.1,2
 
Depending on the intended therapeutic use, various degrees of porosity may be desired. For example, where immuno-protection is required (e.g., endocrine diseases like diabetes, anemia), the encapsulated cells being transplanted should have a matrix porosity that spares host antibody and/or T-cell attack while allowing for the passage of signaling molecules required for the sustained remedial response. 1 In the case of restorative applications, like tissue regeneration, a matrix susceptible to degradation may be advantageous, in that, once the cells are released, they’re free to work to replace the impaired host extracellular matrix.1 Of course, regardless of the end goal, oxygen, cell nutrients, and metabolites required for cell viability should be allowed to diffuse unhindered for optimal response. This often requires the generation of different concentration gradients to accommodate both the innermost and outermost cells of the capsule.1,2
 
How can a syringe pump help?
 
Hydrogel matrices are processed and molded with the specific transport requirements in mind. The process typically involves gravitational dripping, where the hydrogel precursor material of choice and cells-of- interest are extruded through a small cylinder through which they fall freely into an appropriate hardening bath once the right mass is reached.1 Monodispersion of the encapsulated products and maintenance of cell viability throughout requires careful control of their delivery and execution.2 Once cumbersome and difficult, user-friendly syringe-pump microfluidic platforms allow for highly-precise operation by non-experts. Furthermore, microchannel chip approaches based on flow intensity for encapsulation and droplet formation can also be supported by the appropriate pressure pump, allowing for continuous encapsulation while minimizing human intervention right from the outset.

 

References

1. L. Gasperini, et al., “Natural polymers for the microencapsulation of cells,” J R Soc Interface 11: 20140817, 2014.

2. C. Kim, et al., “A microfluidic manifold with a single pump system to generate highly mono-disperse alginate beads for cell encapsulation,” Biomicrofluidics 8:1-10, 2014.

 

Meet the Sponsor: 

This article is brought to you by Chemyx, Inc. Syringe Pumps by Chemyx are used in top-level biomedical, pharmaceutical, chemical, and petrochemical research, offering highly precise, consistent, and reproducible fluidic delivery. Chemyx pump devices orchestrate the performance of different technologies that make modern research into novel materials, drugs, and energy resources possible. www.chemyx.com

 

Interested in reading more?

Chemyx: Sustained-Release Therapeutic Carriers - The Microencapsulation of Cells

The Scientist ARCHIVES

Become a Member of

Receive full access to more than 35 years of archives, as well as TS Digest, digital editions of The Scientist, feature stories, and much more!
Already a member?